Artisan Partners
LEGN icon

Artisan Partners’s Legend Biotech LEGN Stock Holding History

Artisan Partners’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$45M Sell
1,559,441
-695,047
-31% -$18.7M 0.07% 179
2026
Q1 		$40.8M Sell
2,254,488
-86,586
-4% -$1.65M 0.07% 212
2025
Q4 		$50.9M Sell
2,341,074
-206,878
-8% -$5.93M 0.08% 206
2025
Q3 		$83.1M Buy
2,547,952
+425,684
+20% +$15.7M 0.12% 161
2025
Q2 		$75.3M Buy
2,122,268
+990,500
+88% +$32.1M 0.11% 164
2025
Q1 		$38.4M Sell
1,131,768
-373,794
-25% -$13.4M 0.06% 240
2024
Q4 		$49M Buy
1,505,562
+915,891
+155% +$37.9M 0.07% 238
2024
Q3 		$28.7M Buy
589,671
+113,056
+24% +$6.02M 0.04% 269
2024
Q2 		$21.1M Sell
476,615
-15,484
-3% -$714K 0.03% 281
2024
Q1 		$27.6M Sell
492,099
-25,738
-5% -$1.55M 0.04% 260
2023
Q4 		$31.2M Sell
517,837
-43,435
-8% -$2.75M 0.05% 251
2023
Q3 		$37.7M Sell
561,272
-2,672
-0.5% -$186K 0.06% 224
2023
Q2 		$38.9M Sell
563,944
-486,479
-46% -$31.8M 0.06% 228
2023
Q1 		$50.7M Sell
1,050,423
-15,100
-1% -$739K 0.08% 215
2022
Q4 		$53.2M Sell
1,065,523
-341,244
-24% -$16.5M 0.09% 202
2022
Q3 		$57.4M Sell
1,406,767
-299,749
-18% -$14.1M 0.1% 182
2022
Q2 		$93.9M Sell
1,706,516
-75,569
-4% -$3.19M 0.16% 142
2022
Q1 		$64.8M Sell
1,782,085
-127,400
-7% -$5.03M 0.09% 215
2021
Q4 		$89M Buy
1,909,485
+800,383
+72% +$40.6M 0.11% 195
2021
Q3 		$56.1M Buy
1,109,102
+108,855
+11% +$4.53M 0.07% 233
2021
Q2 		$41.1M Buy
1,000,247
+155,199
+18% +$5.27M 0.05% 258
2021
Q1 		$24.5M Buy
+845,048
New +$23M 0.03% 300

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Artisan Partners's LEGN Position: Q2 2026 in Review

Artisan Partners reduced its Legend Biotech (LEGN) stake by 31% in Q2 2026, selling an estimated $18.7M and leaving 1,559,441 shares worth $45M. The position accounts for 0.07% of the portfolio, ranked #179.

Artisan Partners first reported a position in LEGN in Q1 2021 and has held it in 22 quarters since. The position peaked at $93.9M in Q2 2022. 218 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Artisan Partners held 1,559,441 shares of Legend Biotech worth $45M as of Q2 2026.
  • Artisan Partners sold 695,047 Legend Biotech shares in Q2 2026, an estimated $18.7M.
  • Legend Biotech made up 0.07% of Artisan Partners's portfolio in Q2 2026, its #179 holding.
  • Artisan Partners first reported a position in Legend Biotech in Q1 2021 and has held it in 22 quarters since.
  • Artisan Partners's Legend Biotech position peaked at $93.9M in Q2 2022.
  • 218 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Artisan Partners's 13F filing for Q2 2026, filed 13 Aug 2026.